KEYTRUDA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the KEYTRUDA drug offered from Merck Sharp & Dohme Corp.. This Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | pembrolizumab |
| SUBSTANCE NAME: | PEMBROLIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-01-15 |
| END MARKETING DATE: | 0000-00-00 |
KEYTRUDA HUMAN PRESCRIPTION DRUG Details:
| Item Description | KEYTRUDA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2015-01-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-3026_8435cc61-92b4-4718-ab09-e42585e92d19 |
| PRODUCT NDC: | 0006-3026 |
| APPLICATION NUMBER: | BLA125514 |
Other PEMBROLIZUMAB Pharmaceutical Manufacturers / Labelers:
